BSD Medical Corporation BSDM (Company or BSD) (www.BSDMedical.com), a
leading provider of medical systems that utilize heat therapy to treat cancer,
announced today that the Company has signed an exclusive agreement with Linden
Bioscence Co., Ltd. (Linden), a Taiwan corporation, for the sale and
distribution of BSD's hyperthermia products in Taiwan.
Linden's primary focus will be licensing, marketing and selling the BSD-2000
Hyperthermia System (BSD-2000) in Taiwan. Linden is funded by a large
Taiwanese philanthropic cancer foundation. Per the agreement, Linden is
required to purchase a minimum number of BSD-2000 systems annually over a five
year period, totaling a cumulative $7.1 million in revenue to BSD. Shipment of
the first hyperthermia systems will coincide with Linden's receipt of Taiwan
FDA import license approval.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in